Alpha-GPC or Citicoline? Pick on Form and Choline Per Dose Instead

No trial has compared alpha-GPC and citicoline in healthy adults buying for focus. The only head-to-head evidence, a review of 3 trials in 358 people with dementia disorders, favored alpha-GPC on one overall score and found no difference on memory.

So the choice comes down to the label: the exact form, the milligrams per serving, and how much choline each dose delivers. This page traces each brand claim to the evidence behind it, then shows that arithmetic.

If you take medicines, have surgery scheduled, are pregnant or nursing, or are buying for a child, read the last section first.

Two choline compounds, two names each: alpha-GPC (choline alphoscerate) and citicoline (CDP-choline)

Papers and labels use different names for the same two ingredients. The review discussed here uses “choline alphoscerate” and “citicoline” in its title. A Nectr Energy blog post dated 2/9/2026 calls citicoline “CDP-choline” and alpha-GPC “alpha-glycerophosphocholine.” Look for any of these names on a Supplement Facts panel.

Both deliver choline. Nectr’s post says each carries a share of choline by weight. Choline is a nutrient the body uses to make acetylcholine, a chemical messenger in the nervous system. The NIH Office of Dietary Supplements says the brain and nervous system need choline “to regulate memory, mood, muscle control, and other functions.”

The only head-to-head favored alpha-GPC on one overall score in dementia patients, with no difference on memory

A meta-analysis pools several trials into one estimate. This systematic review and meta-analysis set out to “evaluate and compare the effects of alpha-GPC and citicoline on cognitive impairments, behavioural symptoms, and other clinical conditions.” It included 358 participants across 3 randomized controlled trials, per the Frontiers in Neurology version. Every participant had a dementia disorder.

In a randomized trial, chance decides which compound each person gets.

What it found:

1. Overall score. On the SCAG (Sandoz Clinical Assessment for Geriatric Patients), the alpha-GPC groups did significantly better: weighted mean difference −3.92, 95% confidence interval −7.41 to −0.42 (PMC). In plain words, the average gap favors alpha-GPC, and its likely range stays on that side of zero. The authors conclude that alpha-GPC “is more effective than citicoline in improving the clinical conditions of dementia patients.”
2. Memory and word fluency. There was no significant difference between the two (PMC). These are the outcomes closest to a focus buyer’s question.
3. Dropouts. More people left the alpha-GPC groups: 9.4%, against 6.7% for citicoline (odds ratio 1.44, 95% CI 0.66 to 3.13). The review did not find that gap significant (Frontiers).

The rest of this page refers back to this one population.

The review calls the acetylcholine step preclinical; the brand blog states it as fact

The Frontiers in Neurology text says: “Preclinical data indicate that cholinergic precursors can elevate acetylcholine levels in specific brain regions.” Preclinical means studies done before human trials, such as lab and animal work.

The Nectr Energy post describes both compounds as “cholinergic nootropics that increase acetylcholine levels in the brain.” Set side by side, “can elevate” became “increase,” “specific brain regions” became “the brain,” and “preclinical” was dropped.

The post’s verdict, under a headline about focus, is that citicoline “is the better choice for sustained cognitive enhancement and brain health.” For support, it cites single-compound citicoline studies: McGlade 2012 for attention and Nakazaki 2021 for memory. Those are the brand’s own citations. They test citicoline, not citicoline against alpha-GPC, so they do not answer the head-to-head question.

Each focus claim traces to dementia trials, preclinical data or the brand’s own citations

Claim	Nectr Energy blog (2/9/2026)	Meta-analysis / Frontiers	NIH choline sheet	Type of evidence
Raises acetylcholine	“increase acetylcholine levels in the brain”	“can elevate” levels “in specific brain regions”	—	Preclinical, per the review; the brand states it as fact
Improves cognition	Cites McGlade 2012 (attention) and Nakazaki 2021 (memory) for citicoline	Alpha-GPC better on SCAG (−3.92); no gap on memory or word fluency	Some studies link higher choline intake with better cognitive function	Brand: its own single-compound citations. Review: RCTs (randomized trials) in dementia patients. NIH: observed links
Which one wins head to head	Citicoline “is the better choice”	Alpha-GPC “is more effective than citicoline”	—	Brand: marketing verdict. Review: 3 RCTs pooled
Who was studied in the head-to-head	No head-to-head trial cited	358 people with dementia disorders	—	—
Head-to-head data in healthy adults	None cited	None	“choline supplements do not improve cognition in healthy adults”	NIH summary of other studies, about choline supplements in general
Choline per milligram	Alpha-GPC ~40%, citicoline ~18%	—	Most choline comes from food	Brand figure; NIH consumer guidance

A dash means this page cites no claim from that source for that row. To sort a product page, find its claim in the first column, then read the last column.

The NIH sheet gives both sides: some studies link higher choline intake (and higher blood levels) with better cognitive function, while other studies show that choline supplements do not improve cognition in healthy adults. Neither line tests alpha-GPC against citicoline.

Buy on form, milligrams and choline per dose, because no trial settles focus

The weak point first. A healthy adult buying either compound for focus has no head-to-head data to go on, and a product backed only by the dementia review or the acetylcholine mechanism has not shown a focus result.

Who should skip both: if you only want to reach your daily choline amount, use food. The NIH says you can get recommended amounts of choline by eating a variety of foods.

If you still want one of the two, the checks below cover what the label delivers, not what it will do.

1. Find the exact form. “Choline” on its own does not mean alpha-GPC or citicoline. The NIH says supplement choline often comes as choline bitartrate, phosphatidylcholine or lecithin. Look for alpha-GPC, choline alphoscerate, citicoline or CDP-choline by name.
2. Find the milligrams of that compound per serving. If the panel gives only one combined weight for a blend of ingredients, you cannot do steps 3 and 4. The fix: choose a product that lists the milligrams of each ingredient.
3. Do the servings math. Servings needed = target daily dose ÷ mg per serving. Cost per day = (price ÷ servings per container) × servings needed. Take the price from the brand’s own page. The review’s summary does not list each trial’s dose, so get the dose from the individual trial before you use it as a target.
4. Convert compound weight to choline weight. A milligram of either compound is not a milligram of choline. Using Nectr’s figures (alpha-GPC about 40% choline by weight, citicoline about 18%), 300 mg of alpha-GPC carries about 300 × 0.40 = 120 mg of choline, and 300 mg of citicoline about 300 × 0.18 = 54 mg. Against the NIH adult amounts (550 mg a day for men, 425 mg for women, ages 19+), 120 mg is about 22% to 28% of a day, and 54 mg about 10% to 13%.
5. Sort the page’s claims with the table. “Raises acetylcholine” goes in the preclinical row. “Better for focus” goes in the row with no head-to-head data in healthy adults.

Next step: read more in Ingredient evidence on FocusIQ.

FAQ

Are the PMC and Frontiers links two different studies?

No. They are the same systematic review. The PMC copy sits in the NIH’s article archive, and the Frontiers page is the journal’s own version.

Did more people stop taking alpha-GPC in the trials?

Slightly more did: 9.4% of the alpha-GPC groups dropped out, against 6.7% for citicoline. The review found the gap not significant (odds ratio 1.44, 95% CI 0.66 to 3.13), per Frontiers.

Can I get enough choline without either supplement?

Yes, for most people. The NIH says most of the choline in your body comes from the food you eat, and that a variety of foods can supply the recommended amounts.

For more on this topic, see the Ingredient evidence guides.

Who should check with a clinician first

Talk to a doctor or pharmacist before buying either compound if any of these apply:

• You take prescription or over-the-counter medicines. The NIH says supplements “can also interact with some medicines in ways that might cause problems” (NIH, What You Need to Know).
• You have surgery scheduled. The same NIH page says some supplements can increase the risk of bleeding or, if taken before surgery, change your response to anesthesia.
• You are pregnant or nursing. The NIH advises caution with supplements beyond a standard prenatal one (NIH, What You Need to Know).
• You are thinking of giving either product to a child. The NIH says to be careful unless the child’s health care provider recommends it (NIH, What You Need to Know).

Bring the Supplement Facts panel with you.

This page explains published research and label arithmetic. It is not medical advice and promises no result.